Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.49 |
| ▸ | RAB9A | P51151 | 2/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.49 |
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | MAPT | P10636 | 6/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.47 |
| ▸ | THRB | P10828 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | POLQ | O75417 | 1/20 | 0.43 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.42 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.42 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.42 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.42 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.42 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.42 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8394454 | 0.79 | JUN (0.57) | KMT2AKDM4ERAB9AHSD17B10MEN1 | |
| SCHEMBL20850165 | 0.78 | MAPT (0.53) | KMT2AKDM4ERAB9AHSD17B10MEN1 | |
| SCHEMBL18816928 | 0.78 | DHODH (0.52) | KMT2AKDM4EMEN1MAPTNR4A2 | |
| SCHEMBL25545582 | 0.76 | KMT2A (0.49) | KMT2AKDM4ERAB9AHSD17B10MEN1 | |
| SCHEMBL30295565 | 0.76 | KMT2A (0.49) | KMT2AKDM4ERAB9AHSD17B10MEN1 | |
| SCHEMBL1610957 | 0.75 | KMT2A (0.55) | KMT2AKDM4ERAB9AHSD17B10MEN1 | |
| SCHEMBL30171520 | 0.75 | PTGS1 (0.51) | KDM4ETDP1NPC1ALDH1A1POLB | |
| SCHEMBL28405722 | 0.75 | PTGS1 (0.51) | KDM4ETDP1NPC1ALDH1A1POLB | |
| SCHEMBL25547359 | 0.75 | POLQ (0.54) | KMT2AKDM4ERAB9AHSD17B10MEN1 | |
| SCHEMBL25546300 | 0.75 | MAPT (0.51) | KMT2AKDM4ERAB9AHSD17B10MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3466937-B1 | PHOTOELECTRIC CONVERSION ELEMENT, TWO-DIMENSIONAL SENSOR, IMAGE SENSOR AND IMAGING DEVICE | CANON KK (JP) | 2021-03-24 | — | — | EP | disclosed |
| US-10947212-B2 | Photoelectric conversion element, two-dimensional sensor, image sensor, and image pickup device | CANON KABUSHIKI KAISHA (JP) | 2021-03-16 | — | — | US | disclosed |
| EP-3466937-A1 | PHOTOELECTRIC CONVERSION ELEMENT, TWO-DIMENSIONAL SENSOR, IMAGE SENSOR AND IMAGING DEVICE | C/o Canon Kabushiki Kaisha (JP) | 2019-04-10 | — | — | EP | disclosed |
| US-20190092743-A1 | PHOTOELECTRIC CONVERSION ELEMENT, TWO-DIMENSIONAL SENSOR, IMAGE SENSOR, AND IMAGE PICKUP DEVICE | CANON KABUSHIKI KAISHA (JP) | 2019-03-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190092743-A1 | PHOTOELECTRIC CONVERSION ELEMENT, TWO-DIMENSIONAL SENSOR, IMAGE SENSOR, AND IMAGE PICKUP DEVICE | NR2E3, CRY2, GPR3 | KMT2A 2556/4885KDM4E 2895/4885RAB9A 3973/4885 |
| US-10947212-B2 | Photoelectric conversion element, two-dimensional sensor, image sensor, and image pickup device | NR2E3, CRY2, GPR3 | KMT2A 2556/4885KDM4E 2895/4885RAB9A 3973/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.